COLLATERAL

Collateral about our tissue analysis services, processes, technology, and regulatory support for pharma and clinical diagnostics.


eGuidebook: Accelerating Drug Development Through Innovative Tissue Analysis

Explore our guide for key scientists and managers in immuno-oncology drug development

Our Process at Flagship Biosciences

Our flyer shares how, by combining patented technology with a unique, proprietary process, Flagship delivers better data with more actionable insights

Driving Your Biomarker Strategy: Facts by the Numbers

This info. sheet explains how Flagship provides rich, contextual biomarker data services, powered by proprietary image analysis technology, that empowers our pharmaceutical partners to make confident clinical decisions

Phase 1 Through Companion Diagnostics (CDx) Support

Discover how drug development success improves with co-development of an appropriate companion diagnostic biomarker in this detailed info. sheet

Global Regulatory Strategy And Regulatory Submission Support

Learn about Flagship’s regulatory support for your development team through every phase of your drug development life cycle in this info. sheet

Tissue Image Analysis and Biomarker Assessment Implementation Benefits

This white paper shows how you can improve your return on investment, accelerate trials, and minimize budget impacts